Johanna M Geleijnse Selected Research

alpha-Linolenic Acid (Linolenic Acid)

12/2021	Dietary and Circulating Long-Chain Omega-3 Polyunsaturated Fatty Acids and Mortality Risk After Myocardial Infarction: A Long-Term Follow-Up of the Alpha Omega Cohort.
11/2017	Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.
5/2015	No effect of n-3 fatty acids supplementation on NT-proBNP after myocardial infarction: the Alpha Omega Trial.
11/2014	No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.
7/2012	Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients.
3/2011	Alpha-linolenic acid intake and 10-year incidence of coronary heart disease and stroke in 20,000 middle-aged men and women in the Netherlands.
11/2010	n-3 fatty acids and cardiovascular events after myocardial infarction.
4/2010	Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johanna M Geleijnse Research Topics

Disease

30	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 05/2002
28	Myocardial Infarction 12/2021 - 05/2002
27	Hypertension (High Blood Pressure) 07/2018 - 11/2002
12	Stroke (Strokes) 04/2018 - 12/2003
11	Coronary Disease (Coronary Heart Disease) 12/2021 - 11/2004
10	Inflammation (Inflammations) 01/2018 - 05/2004
10	Overweight 03/2016 - 09/2004
9	Type 2 Diabetes Mellitus (MODY) 01/2021 - 11/2009
6	Atherosclerosis 07/2015 - 08/2002
5	Chronic Renal Insufficiency 01/2020 - 10/2014
5	Myocardial Ischemia (Ischemic Heart Diseases) 10/2017 - 05/2002
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 08/2005
4	Heart Failure 01/2017 - 10/2009
3	Insulin Resistance 01/2019 - 05/2004
3	Celiac Disease (Celiac Sprue) 01/2015 - 01/2014
3	Chronic Disease (Chronic Diseases) 03/2014 - 11/2004
3	Obesity 01/2012 - 05/2004
2	Neoplasms (Cancer) 01/2020 - 12/2017
2	Diabetes Mellitus 01/2019 - 03/2015
2	Ischemic Stroke 01/2019 - 01/2017
2	Major Depressive Disorder (Major Depressive Disorders) 01/2015 - 01/2014
2	Vascular Calcification 01/2012 - 11/2004
1	Body Weight (Weight, Body) 01/2022
1	Avoidant Restrictive Food Intake Disorder 10/2021
1	Hypercholesterolemia 01/2018
1	Communicable Diseases (Infectious Diseases) 12/2017
1	Heart Diseases (Heart Disease) 09/2017
1	Albuminuria 05/2016

Drug/Important Bio-Agent (IBA)

18	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2021 - 04/2006
13	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 05/2010
12	Eicosapentaenoic AcidIBA 01/2018 - 04/2006
11	Docosahexaenoic AcidsIBA 12/2021 - 04/2006
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2010
10	Proteins (Proteins, Gene)FDA Link 03/2016 - 11/2004
8	alpha-Linolenic Acid (Linolenic Acid)IBA 12/2021 - 04/2010
8	Dietary ProteinsIBA 01/2020 - 08/2010
7	SodiumIBA 05/2016 - 09/2004
5	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2021 - 01/2013
5	Coffee FDA Link 01/2020 - 05/2005
5	C-Reactive ProteinIBA 04/2018 - 08/2005
5	PotassiumIBA 05/2016 - 09/2004
5	SaltsIBA 01/2015 - 11/2002
5	Antihypertensive Agents (Antihypertensives)IBA 11/2014 - 03/2007
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2021 - 07/2012
4	Cystatin CIBA 01/2020 - 10/2014
4	CreatinineIBA 01/2020 - 10/2014
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 05/2015
4	CarbohydratesIBA 01/2019 - 01/2012
4	HDL CholesterolIBA 01/2019 - 09/2008
4	Insulin (Novolin)FDA Link 01/2019 - 12/2010
4	LipidsIBA 01/2018 - 09/2008
4	MagnesiumIBA 05/2016 - 06/2013
4	TeaIBA 01/2016 - 05/2002
3	Caffeine (No Doz)FDA LinkGeneric 01/2020 - 05/2005
3	Linoleic Acid (Linoleate)IBA 01/2020 - 12/2017
3	CholesterolIBA 01/2019 - 11/2004
3	Catechin (Z 7300)IBA 01/2018 - 05/2015
3	FlavonoidsIBA 07/2015 - 05/2002
3	AcidsIBA 01/2013 - 01/2011
3	Vitamin K FDA Link 01/2012 - 11/2004
3	Plasminogen Activator Inhibitor 1IBA 05/2004 - 08/2002
2	Meat ProteinsIBA 10/2021 - 11/2012
2	Arachidonic Acid (Vitamin F)IBA 01/2019 - 12/2017
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 01/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 12/2017
2	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 01/2019 - 12/2017
2	HaptoglobinsIBA 04/2018 - 10/2017
2	Pharmaceutical PreparationsIBA 09/2017 - 01/2012
2	Dietary PotassiumIBA 05/2016 - 01/2007
2	maltodextrinIBA 03/2016 - 04/2012
2	QuercetinIBA 07/2015 - 05/2002
2	pro-brain natriuretic peptide (1-76)IBA 05/2015 - 03/2014
2	Essential Amino AcidsIBA 01/2015 - 01/2015
2	Vitamin D FDA LinkGeneric 01/2015 - 03/2011
2	MargarineIBA 01/2013 - 11/2010
2	Fish OilsIBA 02/2012 - 09/2005
2	Matrix Gla ProteinIBA 01/2012 - 11/2004
2	IronIBA 08/2010 - 02/2008
2	Vitamin K 2 (Vitamin K2)IBA 04/2009 - 11/2004
1	NitrogenIBA 01/2022
1	Fatty Acid DesaturasesIBA 01/2019
1	palmitoleic acidIBA 10/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 07/2018
1	oxidized low density lipoproteinIBA 07/2018
1	CytokinesIBA 01/2018
1	TubulinIBA 01/2018
1	flavan-3-olIBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018
1	VitaminsIBA 12/2017
1	Cholesterol Esters (Cholesteryl Esters)IBA 12/2017
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2017
1	Fibroblast Growth Factor-23IBA 11/2017
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2017
1	Monounsaturated Fatty AcidsIBA 09/2017
1	Trans Fatty AcidsIBA 09/2017
1	lardIBA 01/2017
1	Apolipoprotein E4IBA 01/2016

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2018 - 01/2017
2	Secondary Prevention 01/2017 - 02/2012
2	Gluten-Free Diet 01/2015 - 01/2015